Literature DB >> 15623087

GM2-gangliosidosis variant 0 (Sandhoff-like disease) in a family of Japanese domestic cats.

O Yamato1, S Matsunaga, K Takata, K Uetsuka, H Satoh, T Shoda, Y Baba, A Yasoshima, K Kato, K Takahashi, M Yamasaki, H Nakayama, K Doi, Y Maede, H Ogawa.   

Abstract

A five-month-old, female Japanese domestic shorthair cat with proportionate dwarfism developed neurological disorders, including ataxia, decreased postural responses and generalised body and head tremors, at between two and five months of age. Leucocytosis due to lymphocytosis with abnormal cytoplasmic vacuolations was observed. The concentration of G(M2)-ganglioside in its cerebrospinal fluid was markedly higher than in normal cats, and the activities of beta-hexosaminidases A and B in its leucocytes were markedly reduced. On the basis of these biochemical data, the cat was diagnosed antemortem with G(M2)-gangliosidosis variant 0 (Sandhoff-like disease). The neurological signs became more severe and the cat died at 10 months of age. Histopathologically, neurons throughout the central nervous system were distended, and an ultrastructural study revealed membranous cytoplasmic bodies in these distended neurons. The compound which accumulated in the brain was identified as G(M2)-ganglioside, confirming G(M2)-gangliosidosis. A family study revealed that there were probable heterozygous carriers in which the activities of leucocyte beta-hexosaminidases A and B were less than half the normal value. The Sandhoff-like disease observed in this family of Japanese domestic cats is the first occurrence reported in Japan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623087

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  7 in total

Review 1.  Inherited metabolic disease in companion animals: searching for nature's mistakes.

Authors:  Adrian C Sewell; Mark E Haskins; Urs Giger
Journal:  Vet J       Date:  2006-11-07       Impact factor: 2.688

Review 2.  A review of gene therapy in canine and feline models of lysosomal storage disorders.

Authors:  Allison M Bradbury; Brittney L Gurda; Margret L Casal; Katherine P Ponder; Charles H Vite; Mark E Haskins
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-11       Impact factor: 5.032

3.  Dried blood spots for the enzymatic diagnosis of lysosomal storage diseases in dogs and cats.

Authors:  Adrian C Sewell; Mark E Haskins; Urs Giger
Journal:  Vet Clin Pathol       Date:  2012-11-02       Impact factor: 1.180

Review 4.  Animal models of GM2 gangliosidosis: utility and limitations.

Authors:  Cheryl A Lawson; Douglas R Martin
Journal:  Appl Clin Genet       Date:  2016-07-20

5.  Skeletal radiographic manifestations of GM2 gangliosidosis variant 0 (Sandhoff disease) in two Japanese domestic cats.

Authors:  Yoshihiko Yu; Daisuke Hasegawa; Yuji Hamamoto; Shunta Mizoguchi; Toshiki Fujimori; Yoshiaki Kubo; Md Shafiqul Islam; Osamu Yamato
Journal:  JFMS Open Rep       Date:  2022-02-14

6.  Real-time PCR genotyping assay for GM2 gangliosidosis variant 0 in toy poodles and the mutant allele frequency in Japan.

Authors:  Mohammad Mahbubur Rahman; Akira Yabuki; Moeko Kohyama; Sawane Mitani; Keijiro Mizukami; Mohammad Mejbah Uddin; Hye-Sook Chang; Kazuya Kushida; Miori Kishimoto; Remi Yamabe; Osamu Yamato
Journal:  J Vet Med Sci       Date:  2013-10-25       Impact factor: 1.267

7.  In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.

Authors:  Moeko Kohyama; Akira Yabuki; Kenji Ochiai; Yuya Nakamoto; Kazuyuki Uchida; Daisuke Hasegawa; Kimimasa Takahashi; Hiroaki Kawaguchi; Masaya Tsuboi; Osamu Yamato
Journal:  BMC Vet Res       Date:  2016-03-31       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.